Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability
- PMID: 32313197
- DOI: 10.1038/s10038-020-0764-4
Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability
Abstract
Variants in SLC35C1 underlie leucocyte adhesion deficiency (LADII) or congenital disorder of glycosylation type 2c (CDGIIc), an autosomal recessive disorder of fucosylation. This immunodeficiency syndrome is generally characterized by severe recurrent infections, Bombay blood group, reduced growth and intellectual disability (ID). Features are all caused by an inability to generate key fucosylated molecules due to a defective transport of GDP-fucose into the Golgi. Here we report the use of exome sequencing to identify biallelic variants in SLC35C1 (c.501_503delCTT, p.(Phe168del) and c.891T > G, p.(Asn297Lys)) in an individual with short stature and ID. Retrospective clinical examination based on the genetic findings revealed increased otitis media as the only immunological feature present in this child. Biochemical analysis of patient serum identified a clear but mild decrease in protein fucosylation. Modelling all described missense mutations on a SLC35C1 protein model showed pathogenic substitutions localise to close to the dimer interface, providing insight into the possible pathophysiology of non-synonymous causative variants identified in patients. Our evidence confirms this is the second family presenting with only a subset of features and broadens the clinical presentation of this syndrome. Of note, both families segregated a common allele (p.Phe168del), suggesting there could be an associated genotype-phenotype relationship for specific variants. Based on two out of 14 reported families not presenting with the characteristic features of SLC35C1-CDG, we suggest there is clinical utility in considering this gene in patients with short stature and ID.
Similar articles
-
Congenital disorders of glycosylation with defective fucosylation.J Inherit Metab Dis. 2021 Nov;44(6):1441-1452. doi: 10.1002/jimd.12426. Epub 2021 Sep 15. J Inherit Metab Dis. 2021. PMID: 34389986
-
Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect.Hum Mol Genet. 2014 Jun 1;23(11):2880-7. doi: 10.1093/hmg/ddu001. Epub 2014 Jan 8. Hum Mol Genet. 2014. PMID: 24403049 Free PMC article.
-
Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1-congenital disorder of glycosylation) and response to l-fucose therapy: Insights from two new families and review of the literature.Am J Med Genet A. 2022 Jul;188(7):2005-2018. doi: 10.1002/ajmg.a.62737. Epub 2022 Mar 26. Am J Med Genet A. 2022. PMID: 35338746 Review.
-
TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.Genet Med. 2022 Apr;24(4):894-904. doi: 10.1016/j.gim.2021.12.012. Epub 2022 Jan 15. Genet Med. 2022. PMID: 35042660
-
A combination of two novels homozygous FCSK variants cause disorder of glycosylation with defective fucosylation: New patient and literature review.Eur J Med Genet. 2022 Aug;65(8):104535. doi: 10.1016/j.ejmg.2022.104535. Epub 2022 Jun 16. Eur J Med Genet. 2022. PMID: 35718084 Review.
Cited by
-
In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2.J Biol Chem. 2023 Dec;299(12):105406. doi: 10.1016/j.jbc.2023.105406. Epub 2023 Oct 28. J Biol Chem. 2023. PMID: 38270391 Free PMC article.
-
Extending the PAX1 spectrum: a dominantly inherited variant causes oculo-auriculo-vertebral syndrome.Eur J Hum Genet. 2022 Oct;30(10):1178-1181. doi: 10.1038/s41431-022-01154-2. Epub 2022 Jul 25. Eur J Hum Genet. 2022. PMID: 35879406 Free PMC article.
-
Treatment Options in Congenital Disorders of Glycosylation.Front Genet. 2021 Sep 10;12:735348. doi: 10.3389/fgene.2021.735348. eCollection 2021. Front Genet. 2021. PMID: 34567084 Free PMC article. Review.
-
Congenital Disorders of Glycosylation: What Clinicians Need to Know?Front Pediatr. 2021 Sep 3;9:715151. doi: 10.3389/fped.2021.715151. eCollection 2021. Front Pediatr. 2021. PMID: 34540767 Free PMC article. Review.
-
Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India.Front Immunol. 2020 Dec 16;11:612703. doi: 10.3389/fimmu.2020.612703. eCollection 2020. Front Immunol. 2020. PMID: 33391282 Free PMC article.
References
-
- Schneider M, Al-Shareffi E, Haltiwanger RS. Biological functions of fucose in mammals. Glycobiology. 2017;27:601–18. - DOI
-
- Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl J Med. 1992;327:1789–92. - DOI
-
- Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297–302. - DOI
-
- Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, et al. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 1996;86:643–53. - DOI
-
- Becker DJ, Lowe JB. Leukocyte adhesion deficiency type II. Biochim Biophys Acta. 1999;1455:193–204. - DOI